153 - Preliminary Results By Age Group of Treatment with CPX-351 Plus Venetoclax in Adults with Newly Diagnosed AML: Subgroup Analysis of the V-FAST Phase 1b Master Trial
- Resource Type
- Abstract
- Source
- In
Transplantation and Cellular Therapy March 2022 28(3) Supplement:S125-S125 - Subject
- Language
- ISSN
- 2666-6367